North Dakota Administrative Code
Title 69.5 - Racing Commission, North Dakota
Article 69.5-01 - North Dakota Racing Commission Rules
Chapter 69.5-01-07 - Conduct of Races
Section 69.5-01-07-18 - Medication
Universal Citation: ND Admin Code ยง 69.5-01-07-18
Current through Supplement No. 394, October, 2024
1. Except as otherwise specifically provided by law, the commission adopts by reference:
a. The association of racing commissioners
international controlled therapeutic medication schedule version
14.4.
b. The association of racing
commissioner's international uniform classification guidelines for foreign
substances and recommended penalties version 14.4.
c. The model rules ARCI-011-020 section
B(13)(a) through (j) of the association of racing commissioners international
model rules of racing version 11.0.
2. Furosemide.
a. Furosemide may be administered
intravenously to a horse, which is entered to compete in a race. Except under
the instructions of the official veterinarian or the racing veterinarian for
the purpose of removing a horse from the veterinarian's list or to facilitate
the collection of a post-race urine sample, furosemide shall be permitted only
after the official veterinarian has placed the horse on the furosemide list. In
order for a horse to be placed on the furosemide list the following process
must be followed.
(1) After the horse's
licensed trainer and licensed veterinarian determine that it would be in the
horse's best interests to race with furosemide the official veterinarian or the
veterinarian's designee shall be notified using the prescribed form, that the
horse is to be put on the furosemide list.
(2) The form must be received by the official
veterinarian or the veterinarian's designee by the proper time deadlines so as
to ensure public notification.
(3)
A horse placed on the official furosemide list must remain on that list unless
the licensed trainer and licensed veterinarian submit a written request to
remove the horse from the list. The request must be made to the official
veterinarian or the veterinarian's designee, on the proper form, no later than
the time of entry.
(4) After a
horse has been removed from the furosemide list, the horse may not be placed
back on the list for a period of sixty calendar days unless it is determined to
be detrimental to the welfare of the horse, in consultation with the official
veterinarian. If a horse is removed from the official furosemide list a second
time in a three hundred sixty-five-day period, the horse may not be placed on
the list for a period of ninety calendar days.
(5) Furosemide shall only be administered on
association grounds.
(6) Furosemide
shall be the only authorized bleeder medication.
b. The use of furosemide shall be permitted
under the following circumstances on association grounds where a detention barn
is utilized:
(1) Furosemide shall be
administered by the official veterinarian or the veterinarian's designee no
less than four hours prior to post time for the race for which the horse is
entered.
(2) A horse qualified for
furosemide administration must be brought to the detention barn within time to
comply with the four-hour administration requirement specified above.
(3) The dose administered shall not exceed
five hundred milligrams nor be less than one hundred fifty
milligrams.
(4) Furosemide shall be
administered by a single, intravenous injection.
(5) After treatment, the horse shall be
required by the commission to remain in the detention barn in the care,
custody, and control of its trainer or the trainer's designated representative
under the association or commission security supervision, or both, until called
to the saddling paddock.
c. The use of furosemide shall be permitted
under the following circumstances on association grounds where a detention barn
is not utilized:
(1) Furosemide shall be
administered by the official veterinarian or the veterinarian's designee no
less than four hours prior to post time for the race for which the horse is
entered.
(2) The furosemide dosage
administered shall not exceed five hundred milligrams nor be less than one
hundred fifty milligrams.
(3)
Furosemide shall be administered by a single, intravenous injection.
(4) After treatment, the horse shall be
required by the commission to remain in the proximity of its stall in the care,
custody, and control of its trainer or the trainer's designated representative
under general association or commission security surveillance, or both, until
called to the saddling paddock.
d. Test result must show a detectable
concentration of the drug in the post-race serum, plasma, or urine sample.
(1) The specific gravity of post-race urine
samples may be measured to ensure the samples are sufficiently concentrated for
proper chemical analysis. The specific gravity shall not be below 1.010. If the
specific gravity of the urine is found to be below 1.010 or if a urine sample
is unavailable for testing, quantitation of furosemide in serum or plasma shall
be performed;
(2) Quantitation of
furosemide in serum or plasma shall be performed when the specific gravity of
the corresponding urine sample is not measured or if measured below 1.010.
Concentrations may not exceed 100 nanograms of furosemide per milliliter of
serum or plasma.
e. The
administering authority or association may assess a fee approved by the
commission on licensed owners of treated horses to recoup the reasonable costs
associated with the administration of furosemide in the manner prescribed in
these rules.
3. Bleeder list.
a. The official veterinarian shall
maintain a bleeder list of all horses, which have demonstrated external
evidence of exercise induced pulmonary hemorrhage from one or both nostrils
during or after a race or workout as observed by the official
veterinarian.
b. Every confirmed
bleeder, regardless of age, shall be placed on the bleeder list and be
ineligible to race for the following time periods:
(1) First incident - Fourteen days;
(2) Second incident within a three hundred
sixty-five-day period - Thirty days;
(3) Third incident within a three hundred
sixty-five-day period - One hundred eighty days;
(4) Fourth incident within a three hundred
sixty-five-day period - Barred for racing lifetime.
c. For the purposes of counting the number of
days a horse is ineligible to run, the day the horse bled externally is the
first day of the recovery period.
d. The voluntary administration of furosemide
without an external bleeding incident shall not subject the horse to the
initial period of ineligibility as defined by this policy.
e. A horse may be removed from the bleeder
list only upon the direction of the official veterinarian, who shall certify in
writing to the stewards the recommendation for removal.
f. A horse which has been placed on a bleeder
list in another jurisdiction pursuant to these rules shall be placed on a
bleeder list in this jurisdiction.
4. Antiulcer medications. The following antiulcer medications are permitted to be administered, at the stated dosage, up to 24 hours prior to the race in which the horse is entered:
a. Cimetidine (Tagamet® - 8-20 mg/kg PO
BID-TID.
b. Opeprazole
(Gastrogard®) - 2.2 grams PO SID.
c. Rantidine (Zantac®) - 8 mg/kg PO
BID.
General Authority: NDCC 53-06.2-04, 53-06.2-05, 53-06.2-10
Law Implemented: NDCC 53-06.2-01, 53-06.2-04, 53-06.2-05, 53-06.2-10
Disclaimer: These regulations may not be the most recent version. North Dakota may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
